Literature DB >> 33652628

'De Novo' Brain AVMs-Hypotheses for Development and a Systematic Review of Reported Cases.

Ioan Alexandru Florian1,2, Lehel Beni1, Vlad Moisoiu1, Teodora Larisa Timis3, Ioan Stefan Florian1,2, Adrian Balașa4,5, Ioana Berindan-Neagoe6.   

Abstract

Background and
Objectives: Brain arteriovenous malformations AVMs have been consistently regarded as congenital malformations of the cerebral vasculature. However, recent case reports describing "de novo AVMs" have sparked a growing debate on the nature of these lesions. Materials and
Methods: We have performed a systematic review of the literature concerning de novo AVMs utilizing the PubMed and Google Academic databases. Termes used in the search were "AVM," "arteriovenous," "de novo," and "acquired," in all possible combinations.
Results: 53 articles including a total of 58 patients harboring allegedly acquired AVMs were identified by researching the literature. Of these, 32 were male (55.17%), and 25 were female (43.10%). Mean age at de novo AVM diagnosis was 27.833 years (standard deviation (SD) of 21.215 years and a 95% confidence interval (CI) of 22.3 to 33.3). Most de novo AVMs were managed via microsurgical resection (20 out of 58, 34.48%), followed by radiosurgery and conservative treatment for 11 patients (18.97%) each, endovascular embolization combined with resection for five patients (8.62%), and embolization alone for three (5.17%), the remaining eight cases (13.79%) having an unspecified therapy. Conclusions: Increasing evidence suggests that some of the AVMs discovered develop some time after birth. We are still a long way from finally elucidating their true nature, though there is reason to believe that they can also appear after birth. Thus, we reason that the de novo AVMs are the result of a 'second hit' of a variable type, such as a previous intracranial hemorrhage or vascular pathology. The congenital or acquired characteristic of AVMs may have a tremendous impact on prognosis, risk of hemorrhage, and short and long-term management.

Entities:  

Keywords:  acquired; arteriovenous malformation; de novo; hemorrhage; seizure

Year:  2021        PMID: 33652628      PMCID: PMC7996785          DOI: 10.3390/medicina57030201

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  112 in total

1.  Acquired cerebral arteriovenous malformation induced by an anaplastic astrocytoma: an interesting case.

Authors:  O A Harris; S D Chang; B T Harris; J R Adler
Journal:  Neurol Res       Date:  2000-07       Impact factor: 2.448

2.  Case report of a de novo brainstem arteriovenous malformation in an 18-year-old male and review of the literature.

Authors:  Kent J Kilbourn; Gary Spiegel; Brendan D Killory; Inam Kureshi
Journal:  Neurosurg Rev       Date:  2014-07-04       Impact factor: 3.042

3.  In Reply: De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain.

Authors:  Makoto Nakamura; Joachim K Krauss
Journal:  Neurosurgery       Date:  2016-04       Impact factor: 4.654

4.  Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations.

Authors:  U Sure; N Butz; J Schlegel; A M Siegel; J P Wakat; H D Mennel; S Bien; H Bertalanffy
Journal:  J Neurosurg       Date:  2001-06       Impact factor: 5.115

5.  Angiographically demonstrated larger vascular malformation in a patient with a normal angiogram 23 years before.

Authors:  F L Peeters
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

6.  Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study.

Authors:  Amparo Wolf; Kyla Naylor; Moses Tam; Akram Habibi; Josef Novotny; Roman Liščák; Nuria Martinez-Moreno; Roberto Martinez-Alvarez; Nathaniel Sisterson; John G Golfinos; Joshua Silverman; Hideyuki Kano; Jason Sheehan; L Dade Lunsford; Douglas Kondziolka
Journal:  Lancet Oncol       Date:  2018-11-22       Impact factor: 41.316

Review 7.  De novo intracerebral arteriovenous malformations and a review of the theories of their formation.

Authors:  A Dalton; G Dobson; M Prasad; N Mukerji
Journal:  Br J Neurosurg       Date:  2018-06-06       Impact factor: 1.596

8.  De novo cerebral arteriovenous malformation: case report.

Authors:  Ketan R Bulsara; Michael J Alexander; Alan T Villavicencio; Carmelo Graffagnino
Journal:  Neurosurgery       Date:  2002-05       Impact factor: 4.654

9.  De novo formation of large arteriovenous shunting and a vascular nidus mimicking an arteriovenous malformation within an anaplastic oligodendroglioma: treatment with embolization and resection.

Authors:  James S McKinney; Thomas Steineke; David Nochlin; Jonathan L Brisman
Journal:  J Neurosurg       Date:  2008-12       Impact factor: 5.115

10.  Delayed presentation of an arteriovenous malformation after cerebellar hemangioblastoma resection-Case report.

Authors:  E Emily Bennett; Balint Otvos; Varun R Kshettry; Jorge Gonzalez-Martinez
Journal:  Int J Surg Case Rep       Date:  2016-03-19
View more
  4 in total

1.  Fatal ruptured occult arteriovenous malformation in a young adult: An autopsy case report.

Authors:  Makiko Oomori; Sayaka Ito; Kazushi Higuchi
Journal:  Surg Neurol Int       Date:  2022-07-01

2.  Multiple De Novo Cerebral Arteriovenous Malformations in a Patient with Alcoholic Liver Cirrhosis.

Authors:  Taehoon Do; Seung-Jae Lee; Jungbin Lee
Journal:  J Belg Soc Radiol       Date:  2022-05-27       Impact factor: 1.912

3.  De novo brain arteriovenous malformation formation and development: A case report.

Authors:  Huan Huang; Xue Wang; An-Na Guo; Wei Li; Ren-Hua Duan; Jun-Hao Fang; Bo Yin; Dan-Dong Li
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

4.  The relationship between spider naevi & de novo arteriovenous malformations in chronic liver disease.

Authors:  Sophia G Connor; Paul M Parizel; Victor Wycoco; David A Prentice
Journal:  BJR Case Rep       Date:  2022-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.